AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca women in senior & middle management roles — Career Level E+ (%) (%)
Sustainability Data Annex — Inclusion & Diversity
Latest, FY2025
48.0%
Period ended Dec 31, 2025
Change on a year earlier
+1.0 pts
47.0% in FY2024
History
4 years
Since FY2022
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Women in senior & middle management roles — Career Level E+ (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 48.0% | +1.0 pts | Sustainability Data Annex 2025 ↗ |
| FY2024 | Dec 31, 2024 | 47.0% | 0.0 pts | Sustainability Data Annex 2025 ↗ |
| FY2023 | Dec 31, 2023 | 47.0% | +1.5 pts | Sustainability Data Annex 2025 ↗ |
| FY2022 | Dec 31, 2022 | 45.5% | – | Sustainability Data Annex 2024 ↗ |
Cite this data
StockData. (2026). AstraZeneca Women in senior & middle management roles — Career Level E+ (%) (%), annual FY2022–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/esg_women_mgmt_all
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.